Literature DB >> 30060326

[2018 Chinese expert-based consensus statement regarding the diagnosis and treatment of interstitial lung disease associated with connective tissue diseases].

.   

Abstract

To establish the experts consensus on diagnosis and treatment of interstitial lung disease (ILD) associated with connective tissue diseases (CTDs). A multidisciplinary consensus development panel was established. The panel of consensus was composed of 41 experts in rheumatology, pulmonology, radiology, most of whom were members of Group of Pulmonary Vascular and Interstitial Diseases Associated with Rheumatic Diseases. The consensus development panel developed 3 major principles and 7 recommendations for the diagnosis and treatment of ILD associated with CTDs. The consensus covered the early screening, diagnosing, disease monitoring and assessing, immunosuppressive and anti-fibrotic therapy with a treat-to-target approach. This consensus was intended to facilitate the decision-making and standardize the care of ILD associated with CTDs in China.

Entities:  

Keywords:  Connective tissue disease; Consensus statement/guidelines; Diagnosis; Interstitial lung disease; Treatment

Mesh:

Substances:

Year:  2018        PMID: 30060326     DOI: 10.3760/cma.j.issn.0578-1426.2018.08.005

Source DB:  PubMed          Journal:  Zhonghua Nei Ke Za Zhi        ISSN: 0578-1426


  6 in total

1.  Circulating Th2 cell reduction and Th1/Th2 imbalance are correlated with primary Sjogren's syndrome-associated interstitial lung disease.

Authors:  Lei Shi; Jia Wang; Hong-Xia Guo; Xiao-Lei Han; Yu-Ping Tang; Guang-Ying Liu
Journal:  Arthritis Res Ther       Date:  2022-05-23       Impact factor: 5.606

2.  [Surgical Treatment of Lung Cancer Combined with Interstitial Lung Disease].

Authors:  Chuan Huang; Chao Ma; Qingjun Wu; Peng Jiao; Yaoguang Sun; Wenxin Tian; Hanbo Yu; Wen Huang; Yongzhong Wang; Hongfeng Tong
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2020-05-20

3.  Invasive mycoses in patients with connective tissue disease from Southern China: clinical features and associated factors.

Authors:  Minxi Lao; Zhongping Zhan; Fan Su; Hao Li; Zheng Yang; Haihong Chen; Liuqin Liang; Dongying Chen
Journal:  Arthritis Res Ther       Date:  2019-03-11       Impact factor: 5.156

4.  β2-microglobulin as a biomarker of pulmonary fibrosis development in COPD patients.

Authors:  Zhenchao Wu; Mengdie Yan; Min Zhang; Nan Wu; Guoyuan Ma; Bingbing Wang; Youbo Fan; Xintong Du; Can Ding; Yi Liu
Journal:  Aging (Albany NY)       Date:  2020-12-21       Impact factor: 5.682

5.  Efficacy and Safety of Tripterygium Wilfordii Hook. F for Connective Tissue Disease-Associated Interstitial Lung Disease:A Systematic Review and Meta-Analysis.

Authors:  Yehui Li; Wen Zhu; Hailang He; Yordan Angelov Garov; Le Bai; Li Zhang; Jing Wang; Jinghai Wang; Xianmei Zhou
Journal:  Front Pharmacol       Date:  2021-06-10       Impact factor: 5.810

Review 6.  [A Case Report of Checkpoint Inhibitor Pneumonitis Caused by PD-1
Antibody-Safety and Effectiveness of Pirfenidone].

Authors:  Haiming Yu; Jinying Li; Lan Yu; Xi Cheng; Xiaona Han; Xiaotao Zhang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2021-06-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.